Karen Johnstone and Sabine Richter, ICON08.22.22
The increasing cost of drug development and commercialization in general – and post marketing surveillance in particular – needs to be at least partially balanced by smarter, leaner, more flexible solutions that contain costs without compromising quality. Outsourcing can be a significant part of the answer, provided that companies work diligently to find the right partner, select the best contracting agreement, and pursue a sound relationship model.
Current Outsourcing Practices
The demand for pharmacovigilance capacity and expertise has been increasing along with more stringent product safety regulations. This is shifting the landscape of pharmacovigilance outsourcing to more complex activities such as signal detection, benefit-risk management, and risk management planning as well as pharmacoeconomics and pharmacoepidemiology. Consequently, many life sciences companies are re-evaluating the way they outsource pharmacovigilance and patient safety services.
Of course, the need for outsourcing varies greatly across companies as it is influenced by a number of factors: t
Current Outsourcing Practices
The demand for pharmacovigilance capacity and expertise has been increasing along with more stringent product safety regulations. This is shifting the landscape of pharmacovigilance outsourcing to more complex activities such as signal detection, benefit-risk management, and risk management planning as well as pharmacoeconomics and pharmacoepidemiology. Consequently, many life sciences companies are re-evaluating the way they outsource pharmacovigilance and patient safety services.
Of course, the need for outsourcing varies greatly across companies as it is influenced by a number of factors: t
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION
